Sam Brusco, Associate Editor06.13.22
Aurora Spine has been issued United States Patent No: 11,331,199 entitled "Spinal Implant for Motion Preservation or Fusion."
The patent covers the company’s ZIPFlex technology for a minimally invasive posterior interlaminar implant for motion preservation that could be adapted into a fusion or non-fusion device while implanted in a patient via a small modular attachment.
Motion preservation surgeries can help to avoid total spinal fusion. A ZIPFlex implant could be inserted as a motion preservation device and months or years later be converted to a fusion implant via a minor keyhole procedure.
ZIPFlex features include individually adjustable anchors to prevent implant migration and unnecessary bone removal to fit the implant.
"Some of the difficulty with traditional spinal fusion systems is that stabilization or additional fusion may be required intraoperatively, particularly to protect adjacent levels after spinal surgery and to protect degenerative segments following decompressive surgery," Steven Falowski, M.D., Director of Functional Neurosurgery at Argires-Marotti Neurosurgical Associates told the press. "Aurora received the ZIPFlex patent, with its proprietary Modular In-Situ Fusion Block, a device that provides the surgeon with the ability to determine whether to stabilize or fuse a patient intraoperatively during the procedure or to allow motion preservation. This is a major step forward in delivering the best options long term for your patients.”
Trent Northcutt, president and CEO of Aurora Spine, added, "As our IP portfolio continues to grow, so does the positive impact we can make for our physician customers and their patients. With this latest patent grant from the USPTO, we have further strengthened our value proposition and the depth and breadth of our portfolio of minimally invasive interlaminar devices.”
The patent covers the company’s ZIPFlex technology for a minimally invasive posterior interlaminar implant for motion preservation that could be adapted into a fusion or non-fusion device while implanted in a patient via a small modular attachment.
Motion preservation surgeries can help to avoid total spinal fusion. A ZIPFlex implant could be inserted as a motion preservation device and months or years later be converted to a fusion implant via a minor keyhole procedure.
ZIPFlex features include individually adjustable anchors to prevent implant migration and unnecessary bone removal to fit the implant.
"Some of the difficulty with traditional spinal fusion systems is that stabilization or additional fusion may be required intraoperatively, particularly to protect adjacent levels after spinal surgery and to protect degenerative segments following decompressive surgery," Steven Falowski, M.D., Director of Functional Neurosurgery at Argires-Marotti Neurosurgical Associates told the press. "Aurora received the ZIPFlex patent, with its proprietary Modular In-Situ Fusion Block, a device that provides the surgeon with the ability to determine whether to stabilize or fuse a patient intraoperatively during the procedure or to allow motion preservation. This is a major step forward in delivering the best options long term for your patients.”
Trent Northcutt, president and CEO of Aurora Spine, added, "As our IP portfolio continues to grow, so does the positive impact we can make for our physician customers and their patients. With this latest patent grant from the USPTO, we have further strengthened our value proposition and the depth and breadth of our portfolio of minimally invasive interlaminar devices.”